Organisation paid for research Program year 2021 Source: CMS Open Payments

Asclepes Research Centers P C

Neither a doctor nor a teaching hospital

Research payments

$15,638

4 payments

Through program year 2021, Asclepes Research Centers P C is reported as receiving $15,638 in research payments, across 4 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2021	Research	$1,800	1
2020	Research	$7,150	2
2019	Research	$6,688	1

Breakdown

Who paid Research payments · program years 2019–2021

AstraZeneca UK Limited $8,488 2 payments
AstraZeneca Pharmaceuticals LP $7,150 2 payments

Studies the money was for Research payments · program years 2019–2021

A 26 Week Multicenter Randomized Placebo Controlled Double Blind Parallel Group Phase 3 Trial with a 26 Week Safety Extension Period Evaluating the Safety and Efficacy of Dapagliflozin 5 and 10 mg and Saxagliptin 2.5 and 5 mg in Pediatric Patients with Type 2 Diabetes Mellitus who are between 10 and below 18 years of age $8,488 2 payments
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Pharmacodynamic Effects of MEDI0382 in Obese Subjects With Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH) $7,150 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.